Product Description
This digital document is an article from Internal Medicine News, published by International Medical News Group on December 1, 2008. The length of the article is 895 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available immediately after purchase. You can view it with any web browser.

Citation Details
Title: Gene variants can predict mortality in multiple myeloma.(GENETICS IN YOUR PRACTICE)(Disease/Disorder overview)
Author: Michele G. Sullivan
Publication: Internal Medicine News (Magazine/Journal)
Date: December 1, 2008
Publisher: International Medical News Group
Volume: 41Issue: 23Page: 30(1)

Article Type: Disease/Disorder overview

Distributed by Gale, a part of Cengage Learning ... Read more

Product Description

Students, researchers, and patients can find reliable, up-to-date and clearly written information in “The Gale Encyclopedia of Cancer,” a comprehensive survey of 120 cancers, cancer drugs, traditional and alternative treatments and diagnostic procedures.

Product Description
This digital document is an article from Health News, published by Belvoir Media Group, LLC on April 1, 2010. The length of the article is 740 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available immediately after purchase. You can view it with any web browser.

Citation Details
Title: More promising treatment for multiple myeloma: combinations of drugs may supplant current standards of care in view of new drug data.(CANCER)
Author: Kathleen E. Lambert
Publication: Health News (Magazine/Journal)
Date: April 1, 2010
Publisher: Belvoir Media Group, LLC
Volume: 16Issue: 4Page: 7(1)

Distributed by Gale, a part of Cengage Learning ... Read more

Product Description
This digital document is an article from Southern Medical Journal, published by Southern Medical Association on October 1, 2001. The length of the article is 1217 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

Citation Details
Title: Multiple myeloma-associated amyloidosis manifesting as fulminant hepatic failure.
Author: Noel C. Ales
Publication: Southern Medical Journal (Refereed)
Date: October 1, 2001
Publisher: Southern Medical Association
Volume: 94Issue: 10Page: 1036(3)

Distributed by Thomson Gale ... Read more

Product Description
This digital document is an article from Biotech Business, published by Worldwide Videotex on July 1, 2002. The length of the article is 1402 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

Citation Details
Title: MILLENNIUM'S MLN341 EFFECTIVE AGAINST MULTIPLE MYELOMA.
Publication: Biotech Business (Newsletter)
Date: July 1, 2002
Publisher: Worldwide Videotex
Volume: 15Issue: 7Page: NA

Distributed by Thomson Gale ... Read more

Product Description
The Symmetry of Birth and Death

Eleanor Rawlings, a 34-year-old Chicago physician, is abandoned by her husband just as she conceives. Her husband disappears when he is indicted by a federal grand jury for a massive financial fraud. Only Daughters is the story of Eleanor's struggle against an aggressive and self-serving media and the escalating violence surrounding her fugitive husband.

A story of intrigue, Only Daughters deals with Dr. Eleanor Rawlings' battle to reshape her life. Her drama passes through infertility, conception, abortion, miscarriage, birth, death, and love. She must finally confront the force which threatens to forever destroy her dreams ... Read more

Customer Reviews (1)

Not Only for Only Daughters
With ONLY DAUGHTERS, Bob McDavid rushes headlong into the world of murder mystery mayhem.From the time Eleanor Rawlings' husband disappears, with the FBI in hot pursuit, to the surprise action-packed ending when Eleanor must confront her worst fears, the reader is on board and eager for more.A first time novelist, McDavid does an outstanding job detailing the intricacies of family relationships and the intertwining connectedness of small town life.This suspense novel is made even more compelling by the author's firsthand knowledge of the joys and the heartbreak of pregnancy and childbirth that he artfully weaves into his storyline.Be warned, you may pick up this page turner and not be able to put it down!After two weeks of reading Forsythe, Le Carre, and Connelly, I was not disappointed by ONLY DAUGHTERS.

... Read more

Product Description
Chapters: Leukemia, Lymphoma, Anemia, Acute Myeloid Leukemia, Sickle-Cell Disease, Multiple Myeloma, B-Cell Chronic Lymphocytic Leukemia, Acute Lymphoblastic Leukemia, Pernicious Anemia, Chronic Myelogenous Leukemia, Polycythemia Vera, Juvenile Myelomonocytic Leukemia, Hemolytic Anemia, Thrombocytopenia, Aplastic Anemia, Large Granular Lymphocytic Leukemia, Megaloblastic Anemia, Hepatosplenic T-Cell Lymphoma, Warm Autoimmune Hemolytic Anemia, Lymphocytopenia, Leukocytosis, Pancytopenia, Left Shift, Hypersegmented Neutrophil, Normocytic Anemia, Macrocytosis, Perls' Prussian Blue, Acute Myeloblastic Leukemia. Source: Wikipedia. Pages: 210. Not illustrated. Free updates online. Purchase includes a free trial membership in the publisher's book club where you can select from more than a million books without charge. Excerpt: Acute myeloid leukemia (AML), also known as acute myelogenous leukemia, is a cancer of the myeloid line of blood cells, characterized by the rapid growth of abnormal white blood cells that accumulate in the bone marrow and interfere with the production of normal blood cells. AML is the most common acute leukemia affecting adults, and its incidence increases with age. Although AML is a relatively rare disease, accounting for approximately 1.2% of cancer deaths in the United States, its incidence is expected to increase as the population ages. The symptoms of AML are caused by replacement of normal bone marrow with leukemic cells, which causes a drop in red blood cells, platelets, and normal white blood cells. These symptoms include fatigue, shortness of breath, easy bruising and bleeding, and increased risk of infection. Although several risk factors for AML have been identified, the specific cause of the disease remains unclear. As an acute leukemia, AML progresses rapidly and is typically fatal within weeks or months if left untreated. AML has several subtypes; treatment and prognosis varies among subtypes....More: http://booksllc.net/?id=4323952 ... Read more

Product Description
This digital document is an article from Internal Medicine News, published by International Medical News Group on March 1, 2002. The length of the article is 557 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

Citation Details
Title: Tandem transplant: 60% remission in Myeloma. (Reduced Relapse and Mortality).(multiple myeloma)
Author: Kathryn DeMott
Publication: Internal Medicine News (Magazine/Journal)
Date: March 1, 2002
Publisher: International Medical News Group
Volume: 35Issue: 5Page: 16(1)

Distributed by Thomson Gale ... Read more

Product Description
This digital document is an article from Internal Medicine News, published by International Medical News Group on March 1, 2002. The length of the article is 902 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

Citation Details
Title: Novel agent stabilizes, aids refractory Myeloma. (Clinical Trials Slated for PS-341).
Author: Kathryn DeMott
Publication: Internal Medicine News (Magazine/Journal)
Date: March 1, 2002
Publisher: International Medical News Group
Volume: 35Issue: 5Page: 17(1)

Distributed by Thomson Gale ... Read more

Product Description
This very provocative book takes the reader on a 'think-out-of-the-box' journey through the development of a treatment regimen for multiple myeloma called 'dtZ'. It is a firsthand account of how more than 50 patients with myeloma were given a non-toxic, precisely-targeted, anti-cancer treatment that was specifically adapted to their individual cancers. These Individualized Anti-Cancer Targeted Therapies (smart bombs) have produced amongst the best responses as well as survival rates for myeloma.Accordingly, the author argues that some patients might even have been 'cured' of their cancers. The concepts and logic behind 'dtZ' are carefully presented in simple language so that both doctors and patients can easily understand them. Numerous tables and figures are provided, together with clear and simple explanations in this book. This book is a valuable resource for all patients with myeloma who want to get the most out of their treatment by individualizing treatment to suit their needs, particularly for patients who have just been diagnosed with myeloma and who are taking that very important first step in their treatment. It is also a useful guide for doctors, nurses and researchers who treat and/or study myeloma. ... Read more

Product Description
discusses the advances in molecular and cellular biology that have affected all fields of biology and have had a tremendous impact on the understanding of the biology of myeloma; reviews the dramatic clinical response to novel agents that has prompted a re-evaluation of important signaling pathways in myeloma; covers bone marrow microenvionments, molecular genetics, and other various genetic changes. ... Read more

Product Description
Multiple Myeloma (MM) is the second most common type of blood cancer, resulting from an overproduction of cancerous infection-fighting white blood cells, known as plasma cells. Plasma cells are a crucial part of the immune system responsible for the production of antibodies. Bortezomib is a promising anticancer drug targeting the proteasome. This proteasome inhibitor induces cell stress and apoptosis in the cancer cells. While multiple mechanisms are likely to be involved, proteasome inhibition may prevent the degradation of pro-apoptotic factors, permitting activation of programmed cell death in neoplastic cells dependent upon the suppression of proapoptotic pathways.This monograph on bortezomib is a valuable source of information for researchers and clinicians from the fields of oncology and pharmacology, working either in academia or the pharmaceutical industry. ... Read more